BackEntasis Therapeutics Holdings Overview
Entasis Therapeutics Holdings Inc

Entasis Therapeutics Holdings Discounted Cash Flow

DCF Analysis for ETTX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$2.87

Current Fair Value

$2.87
31.2% Upside

Undervalued by 31.2% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading